MARINUS PHARMACEUTICALS, INC. - COMMON STOCK (MRNS)

CUSIP: 56854Q200

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / COMMON STOCK
Shares outstanding
54,731,500
Total 13F shares
44,658,216
Share change
+3,525,170
Total reported value
$485,001,751
Put/Call ratio
19%
Price per share
$10.86
Number of holders
104
Value change
+$47,690,063
Number of buys
64
Number of sells
50

Quarterly Holders Quick Answers

What is CUSIP 56854Q200?
CUSIP 56854Q200 identifies MRNS - MARINUS PHARMACEUTICALS, INC. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MARINUS PHARMACEUTICALS, INC. - COMMON STOCK (MRNS) as of Q2 2023

As of 30 Jun 2023, MARINUS PHARMACEUTICALS, INC. - COMMON STOCK (MRNS) was held by 104 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 44,658,216 shares. The largest 10 holders included SUVRETTA CAPITAL MANAGEMENT, LLC, BlackRock Inc., EVENTIDE ASSET MANAGEMENT, LLC, Avoro Capital Advisors LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, Lion Point Capital, LP, Bleichroeder LP, JENNISON ASSOCIATES LLC, and GMT CAPITAL CORP. This page lists 104 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.